New screening procedure on OTC products to be eyed

Published: 2008-07-23 06:58:00

Updated: 2008-07-23 06:58:00

The Korea Food and Drug Administration has unveiled its plan to legislate a bill to separately establish a new screening procedure concerning the safety and efficacy of over-the-counter (OTC) products, aside from the current rules of prescription drugs.

To that end, the Korea Health Industry d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK